Medinice S.A.

Warsaw Stock Exchange ICE.WA

Medinice S.A. Current Liabilities for the year ending December 31, 2023: USD 293.15 K

Medinice S.A. Current Liabilities is USD 293.15 K for the year ending December 31, 2023, a 26.79% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Medinice S.A. Current Liabilities for the year ending December 31, 2022 was USD 231.21 K, a -19.08% change year over year.
Medinice S.A. Current Liabilities for the year ending December 31, 2021 was USD 285.72 K, a -22.72% change year over year.
Medinice S.A. Current Liabilities for the year ending December 31, 2020 was USD 369.74 K, a -52.29% change year over year.
Medinice S.A. Current Liabilities for the year ending December 31, 2019 was USD 774.90 K, a -35.28% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Warsaw Stock Exchange: ICE.WA

Medinice S.A.

CEO	Mr. Sanjeev Choudhary
IPO Date	Sept. 1, 2018
Location	Poland
Headquarters	ul. Chmielna 132/134
Employees	16
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Clinical Trials Pharmaceuticals

Description

Medinice S.A. provides medical solution for cardiology and cardiac surgery. The company support scientists for product commercialization including prototyping, clinical trials and certification, and product sales. Medinice S.A. was founded in 2012 and is based in Warsaw, Poland.

Key trends

Past 5 years